Ay Serhan Serhat, Aslan Selim, Önyay Firdevs, Kaya Duygu, Koldaş Ece, Arslan Serhat, Fındık Murat
1 Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine, Ondokuz Mayıs University, Samsun, Turkey.
2 Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine, Near East University, Nicosia-Turkish, Republic of Northern Cyprus.
J Feline Med Surg. 2019 Aug;21(8):714-722. doi: 10.1177/1098612X18797139. Epub 2018 Sep 19.
This study aimed to determine the efficacy and safety of oral misoprostol (MIS) administration in the induction of mid-term pregnancy termination in cats.
Twenty-eight cats that were pregnant for 30-40 days were allocated to four groups. The aglepristone (AGL) group (n = 7) received 10 mg/kg SC aglepristone q24h for two consecutive days. In the AGL+MIS group (n = 7), AGL (as administered in the AGL group) and MIS (200 µg/cat PO q12h until the start of abortion) were administered. The MIS200 (n = 7) and MIS400 groups (n = 7) received MIS (200 or 400 µg/cat misoprostol, respectively) alone PO q12h until the start of abortion. Blood samples were collected at the start of treatment (d0), 4 days after the start of treatment (d4) and on the day of complete abortion/end of administration (dA/d7).
The efficacy of the treatment was 71.4% in the AGL group, 100% in the AGL+MIS group, 0% in MIS200 group and 57.4% in MIS400 group ( = 0.004). No significance was found in relation to the interval from treatment to the start/end of abortion and the duration of abortion in all groups. The most observed side effect was vomiting in both groups administered MIS, particularly in the MIS400 group (56.7%). Progesterone (P4) concentrations were reduced during the abortion, but not to basal levels, in all groups. P4 concentrations were significantly lower at dA/d7 in the MIS400 group compared with the AGL and AGL+MIS groups ( = 0.002).
The results obtained from this study showed that low doses of MIS do not induce abortions in cats but increase the effect of AGL. Although higher doses could terminate pregnancies, this also causes intense unwanted side effects. Therefore, the use of MIS alone as an abortifacient in cats is not recommended. For mid-term pregnancy termination in cats, the combination of misoprostol and aglepristone provides a more effective abortifacient than using either of them alone.
本研究旨在确定口服米索前列醇(MIS)诱导猫中期妊娠终止的有效性和安全性。
将28只怀孕30 - 40天的猫分为四组。阿孕瑞司酮(AGL)组(n = 7)连续两天每天皮下注射10 mg/kg阿孕瑞司酮,每24小时一次。AGL + MIS组(n = 7)给予AGL(与AGL组给药方式相同)和MIS(200 μg/猫,口服,每12小时一次,直至流产开始)。MIS200组(n = 7)和MIS400组(n = 7)分别单独口服MIS(200或400 μg/猫米索前列醇),每12小时一次,直至流产开始。在治疗开始时(第0天)、治疗开始后4天(第4天)以及完全流产/给药结束当天(流产日/第7天)采集血样。
AGL组治疗有效率为71.4%,AGL + MIS组为100%,MIS200组为0%,MIS400组为57.4%(P = 0.004)。所有组在治疗至流产开始/结束的间隔时间和流产持续时间方面均未发现显著差异。在使用MIS的两组中,最常见的副作用是呕吐,尤其是在MIS400组(56.7%)。所有组在流产期间孕酮(P4)浓度均降低,但未降至基础水平。与AGL组和AGL + MIS组相比,MIS400组在流产日/第7天的P4浓度显著降低(P = 0.002)。
本研究结果表明,低剂量的MIS不能诱导猫流产,但可增强AGL的作用。虽然高剂量可终止妊娠,但也会引起强烈的不良副作用。因此,不建议单独使用MIS作为猫的堕胎药。对于猫的中期妊娠终止,米索前列醇和阿孕瑞司酮联合使用比单独使用任何一种药物都能提供更有效的堕胎效果。